Search
Mainz Biomed N V Ord Shs
QUCYAdd to Watchlist
1.060USD
-0.030-2.75%
Close 10-16 16:00（ET）
24.14MMarket Cap
0.00P/E TTM
Mainz Biomed N V Ord Shs (QUCY) Stock Price Target & Forecast
Analyst Rating
Based on 2 analysts
Buy
0 Strong Buy
1 Buy
1 Hold
0 Sell
0 Strong Sell
Target Price
9.000USD+703.57%
QUCY Analyst Recommendation Trends
In the current month, QUCY has received 1 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. QUCY average Analyst price target in the last month is 9.000.
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
0
0
0
0
0
0
0
0
1
1
0
0
0
0
0
1
1
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
2
1
1
1
1
1
1
QUCY Analyst Rating for Peer Comparison
Updated: Oct 15, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
CVS Health Corp
CVS
7
18
3
0
0
28
HCA Healthcare Inc
HCA
5
10
11
1
0
27
Tenet Healthcare Corp
THC
5
15
4
0
0
24
Natera Inc
NTRA
10
12
2
0
0
24
Teladoc Health Inc
TDOC
2
3
18
0
0
23
Universal Health Services Inc
UHS
2
4
14
1
0
21
Labcorp Holdings Inc
LH
6
8
5
0
0
19
Brightspring Health Services Inc
BTSG
7
12
0
0
0
19
Quest Diagnostics Inc
DGX
5
5
9
0
0
19
Privia Health Group Inc
PRVA
5
12
1
0
0
18
Financial Forecasting
Based on analysts' estimates, QUCY EPS is projected to reach -0.080 in FY2026Q3, following reported EPS of -0.617 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025
FY2026Q1
FY2026Q2
FY2025Q1
FY2026Q3
FY2026Q4
Forecast
--
--
-0.63
-2.80
-0.08
-0.06
Actual
-2.70
-0.43
-0.62
--
--
--
Surprise
--
--
+2.04%
--
--
--
FAQs
What is Mainz Biomed N V Ord Shs's expected revenue for the next quarter?
Mainz Biomed N V Ord Shs's expected revenue is 1.10M.
What is Mainz Biomed N V Ord Shs's price target?
Analysts forecast that Mainz Biomed N V Ord Shs's price target is USD 9.00, with the highest forecast at USD 9.00 and the lowest forecast at USD 9.00.
How have Mainz Biomed N V Ord ShsQUCY's recent earnings per share performed?
The market expectation was USD -0.62, while Mainz Biomed N V Ord ShsQUCY's earnings per share (EPS) for the previous quarter was USD -0.43. EPS for the next quarter is expected at USD -0.06.
What is the analyst rating for Mainz Biomed N V Ord Shs?
Based on the ratings of Mainz Biomed N V Ord Shs's stock from 2 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.